Ankylosing spondylitis (AS) is a chronic form of arthritis. It mostly affects the bones and joints at the base of the spine where it connects with the pelvis. These joints can become swollen and inflamed. Over time, the affected spinal bones may join together.
Spondylitis; Spondyloarthritis; HLA - B27
AS is the main member of a family of similar forms of arthritis called spondyloarthritis. Other members include psoriatic arthritis, arthritis of inflammatory bowel disease and reactive arthritis. This family of arthritis affects up to 1 in 100 people.
The cause of AS is unknown, however genes seem to play a role. The majority of people with AS are positive for the HLA-B27 gene, but not everyone who has this gene has AS.
The disease often begins between ages 20 and 40, but it may begin before age 10. It affects more males than females.
AS starts with lower back pain that comes and goes but usually becomes present most of the time as the condition progresses.
Other parts of your body that may be affected include:
Fatigue is also a common symptom.
Less common symptoms include:
AS may occur with other conditions, such as:
Tests may include:
Your health care provider may prescribe medicines such as non-steroidal anti-inflammatory drugs (NSAIDs) to reduce swelling and pain.
You may also need stronger medicines to control pain and swelling, such as:
Surgery, such as hip replacement, may be done if pain or joint damage is severe.
Exercises can help improve posture and breathing. Lying flat on your back at night can help you keep a normal posture.
The course of the disease is hard to predict. Over time, signs and symptoms of AS flareup (relapse) and quiet down (remit). Most people are able to function well unless they have a lot of damage to the hips or the spine. Joining a support group of others with the same problem may often help.
Treatment with NSAIDs often reduces the pain and swelling. Treatments given by IV or injection such as TNF inhibitors early in the disease appears to slow progression of the spine arthritis. Other newer medicines such as Interleukin-17 inhibitors and oral medicines, JAK inhibitors may help people if other medicines have not worked well.
Rarely, people with ankylosing spondylitis may have problems with:
Contact your provider if:
Inman RD, Fitzgerald G. Classification and epidemiology of spondyloarthritis. In: Firestein GS, McInnes IB, Koretzky GA, Mikuls TR, Neogi T, O'Dell JR, eds. Firestein & Kelley's Textbook of Rheumatology. 12th ed. Philadelphia, PA: Elsevier; 2025:chap 75.
Inman RD, Rahman P. Spondyloarthritis. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 244.
Taylor WJ, van der Linden SJEF, Robinson PC, Brown M, Østergaard M, Gensler LS. Axial spondyloarthritis. In: Firestein GS, McInnes IB, Koretzky GA, Mikuls TR, Neogi T, O'Dell JR, eds. Firestein & Kelley's Textbook of Rheumatology. 12th ed. Philadelphia, PA: Elsevier; 2025:chap 76.
Ward MM, Deodhar A, Gensler LS, et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285-1299. PMID: 31436026 pubmed.ncbi.nlm.nih.gov/31436026/.